Clinical Trials : Bare Lymphocyte Syndrome


Recruiting	: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies : SCID Omenn's Syndrome Reticular Dysgenesis : 2012-07-25 : Drug: Alemtuzumab 0.3 mg 0.3 m